SCHEMBL23535657

SCHEMBL23535657

Brc1cc2ccccn2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.46
RAB9A P51151 5/20 0.46
MAP4K4 O95819 1/20 0.46
ABL1 P00519 1/20 0.46
MAPK8 P45983 1/20 0.46
CSNK1A1 P48729 1/20 0.46
CDK7 P50613 1/20 0.46
TYRO3 Q06418 1/20 0.46
LRRK2 Q5S007 1/20 0.46
AURKB Q96GD4 1/20 0.46
CLK4 Q9HAZ1 1/20 0.46
PIM2 Q9P1W9 1/20 0.46
DYRK1B Q9Y463 1/20 0.46
DRD2 P14416 2/20 0.43
DRD3 P35462 2/20 0.43
HDAC4 P56524 1/20 0.41
KDM4E B2RXH2 3/20 0.40
DRD1 P21728 1/20 0.40
DRD4 P21917 1/20 0.40
TP53 P04637 6/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11660148 0.74 MAP4K4 (0.46) NPC1RAB9AMAP4K4ABL1MAPK8
SCHEMBL26673743 0.74 MAP4K4 (0.46) NPC1RAB9AMAP4K4ABL1MAPK8
SCHEMBL434570 0.74 MAP4K4 (0.54) NPC1RAB9AMAP4K4ABL1MAPK8
SCHEMBL13569111 0.74 MAP4K4 (0.46) NPC1RAB9AMAP4K4ABL1MAPK8
SCHEMBL2849283 0.74 MAP4K4 (0.46) NPC1RAB9AMAP4K4ABL1MAPK8
SCHEMBL29278540 0.74 MAP4K4 (0.46) NPC1RAB9AMAP4K4ABL1MAPK8
SCHEMBL1269053 0.74 MAP4K4 (0.50) NPC1RAB9AMAP4K4ABL1MAPK8
SCHEMBL14809152 0.74 MAP4K4 (0.46) NPC1RAB9AMAP4K4ABL1MAPK8
SCHEMBL1941324 0.74 TP53 (0.47) NPC1RAB9AMAP4K4ABL1MAPK8
SCHEMBL5953401 0.72 HRH3 (0.51) NPC1RAB9AMAP4K4ABL1MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119954831-A Pyrimidopyrazoles, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2025-05-09 CN disclosed
CN-119241532-A 1H-pyrazolo [4,3-c ] pyridine compound, composition and application thereof 深圳市塔吉瑞生物医药有限公司 2025-01-03 CN disclosed
EP-4076438-A1 BICYCLIC HETEROCYCLE COMPOUNDS METHODS OF USE THEREOF FOR THE TREATMENT OF HERPES VIRUSES Merck Sharp & Dohme LLC (US) 2022-10-26 EP disclosed
WO-2021127071-A1 BICYCLIC HETEROCYCLE COMPOUNDS METHODS OF USE THEREOF FOR THE TREATMENT OF HERPES VIRUSES MERCK SHARP & DOHME CORP. (US) 2021-06-24 WO disclosed